Furthermore, fangchinoline and N-gluA-schefferine can prevent the abnormal proliferation of PBMCs, caused by RA, by strongly promoting the modification of a potential new PTM with +845.4540 Da at 220N of Prkca, which may stimulate the ERK1/2 pathway. The gene discussed is MAPK3; the disease is rheumatoid arthritis.